Methods of preventing or treating cell malignancies by administering CD2 antagonists

Details for Australian Patent Application No. 2003273299 (hide)

International Classifications

Event Publications

5 February 2004 Complete Application Filed

Priority application(s): 60/410,385 12.09.02 US; 60/409,024 05.09.02 US

13 May 2004 Application Open to Public Inspection

Published as AU-B-2003273299

2 October 2008 Alteration of Name

The name of the applicant has been altered to National Cancer Institute; MedImmune, LLC

1 April 2010 Application Accepted

Published as AU-B-2003273299

15 July 2010 Application for Amendment

The nature of the amendment is: Add the co-inventors Zhang, Zhuo and Zhang, Meili . Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000 2004

4 November 2010 Amendment Made

The nature of the amendment is: Add the co-inventors Zhang, Zhuo and Zhang, Meili 2004

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.